Clinical Trial Update: Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect on obesity of weekly Nimacimab, with or without co-administration of Semaglutide, compared with placebo; study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Nimacimab (Nimacimab)
• semaglutide (semaglutide)

Snippet

Sponsor: Skye Bioscience, Inc. | Conditions: Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING